Common Contracts
36 similar null contracts by Hannon Armstrong Sustainable Infrastructure Capital, Inc., Dime Community Bancshares Inc, Fulton Financial Corp, others
VINCERX PHARMA, INC. (a Delaware corporation) 6,000,000 Shares of Common Stock Pre-Funded Warrants to Purchase 16,000,000 Shares of Common Stock Warrants to Purchase 22,000,000 Shares of Common Stock UNDERWRITING AGREEMENTVincerx Pharma, Inc. • April 26th, 2024 • Pharmaceutical preparations • New York
TARSUS PHARMACEUTICALS, INC. (a Delaware corporation) 2,812,500 Shares of Common Stock Pre-Funded Warrants to Purchase 312,500 Shares of Common Stock UNDERWRITING AGREEMENTTarsus Pharmaceuticals, Inc. • March 1st, 2024 • Biological products, (no disgnostic substances) • New York
Tarsus Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement with Goldman Sachs & Co. LLC (“Goldman”), BofA Securities, Inc. (“BofA”), Guggenheim Securities, LLC (“Guggenheim”) and each of the other underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Goldman, BofA and Guggenheim are acting as representatives (in such capacity, the “Representatives”), with respect to the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of (i) common stock, par value $0.0001 per share, of the Company (“Common Stock”) and (ii) pre-funded warrants, in the form set forth in Exhibit B hereto, to purchase shares of Common Stock (the “Pre-Funded Warrants”), each as set forth in Schedule A hereto, and (ii) the grant by the Company to the Underwriters, acting severally
PepGen Inc. (a Delaware corporation) 7,530,000 Shares of Common Stock UNDERWRITING AGREEMENTPepGen Inc. • February 7th, 2024 • Pharmaceutical preparations • New York
BIONOMICS LIMITED (A public company limited by shares organized under the laws of the Commonwealth of Australia) 641,026 American Depositary SharesBionomics Limited/Fi • October 18th, 2023 • Pharmaceutical preparations • New York
Bionomics Limited, a public company incorporated under the laws of the Commonwealth of Australia (the “Company”), confirms its agreement with Aegis Capital Corp. (“Aegis”), Berenberg Capital Markets LLC (“Berenberg”) and the other Underwriter named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 11 hereof), for whom Aegis, the lead underwriter, and Berenberg, joint book running manager, are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting
Hannon Armstrong Sustainable Infrastructure Capital, Inc. (a Maryland corporation) 13,043,479 Shares of Common Stock UNDERWRITING AGREEMENTHannon Armstrong Sustainable Infrastructure Capital, Inc. • May 30th, 2023 • Real estate investment trusts • New York
VERRICA PHARMACEUTICALS INC. (a Delaware corporation) 750,000 Shares of Common Stock Pre-Funded Warrants to Purchase 4,064,814 Shares of Common Stock UNDERWRITING AGREEMENTVerrica Pharmaceuticals Inc. • February 21st, 2023 • Pharmaceutical preparations • New York
CNB FINANCIAL CORPORATION (a Pennsylvania corporation) Common Stock, no par value UNDERWRITING AGREEMENTCNB Financial Corp/Pa • September 21st, 2022 • State commercial banks • New York
CHINOOK THERAPEUTICS, INC. (a Delaware corporation) 6,428,572 Shares of Common Stock and Pre-Funded Warrants to Purchase 1,071,428 Shares of Common Stock UNDERWRITING AGREEMENTChinook Therapeutics, Inc. • May 25th, 2022 • Pharmaceutical preparations • New York
Common Warrants to Purchase up to 35,714,286 Shares of Common Stock UNDERWRITING AGREEMENTGeron Corp • March 30th, 2022 • Pharmaceutical preparations • New York
Commission on Form 4 in accordance with Section 16(a) (“Section 16(a)”) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the Lock-Up Period, and (2) not apply to the exercise of any option, warrant or other right to acquire shares of Common Stock on a cash basis or the conversion of any convertible security into securities of the Company, provided that in any such case, the Common Stock issued upon such exercise, settlement or conversion shall remain subject to the provisions of this lock-up agreement.
Compass Therapeutics, Inc. (a Delaware corporation) 35,715,000 Shares of Common Stock UNDERWRITING AGREEMENTCompass Therapeutics, Inc. • November 3rd, 2021 • Biological products, (no disgnostic substances) • New York
MONTROSE ENVIRONMENTAL GROUP, INC. (a Delaware corporation) 2,500,000 Shares of Common Stock UNDERWRITING AGREEMENTMontrose Environmental Group, Inc. • September 30th, 2021 • Services-management consulting services • New York
Montrose Environmental Group, Inc., a Delaware corporation (the “Company”), confirms its agreement with J.P. Morgan Securities LLC (“JPM”), BofA Securities, Inc. (“BofA”), William Blair & Company, L.L.C. (“William Blair”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom JPM, BofA and William Blair are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of Common Stock, par value $0.000004 per share, of the Company (“Common Stock”) set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 375,000 additional shares of Common
UNDERWRITING AGREEMENTCastle Biosciences Inc • December 16th, 2020 • Services-medical laboratories • New York
8,000,000 Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A FULTON FINANCIAL CORPORATION UNDERWRITING AGREEMENTFulton Financial Corp • October 23rd, 2020 • National commercial banks • New York
II-VI INCORPORATED (a Pennsylvania corporation) 9,302,235 Shares of Common Stock UNDERWRITING AGREEMENTIi-Vi Inc • July 7th, 2020 • Optical instruments & lenses • New York
transfer or dispose of any shares of the Common Stock, or any securities convertible into or exercisable or exchangeable for Common Stock, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively, the “Lock-Up Securities”), or exercise any right with respect to the registration of any of the Lock-Up Securities, or file or cause to be filed any registration statement in connection therewith, under the Securities Act of 1933, as amended, or (y) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of Common Stock or other securities, in cash or otherwise.
Dime Community Bancshares, Inc. 2,000,000 Shares 5.50% Fixed-Rate Non- Cumulative Perpetual Preferred Stock, Series A Underwriting AgreementDime Community Bancshares Inc • June 4th, 2020 • Savings institution, federally chartered • New York
EX-1.1 2 d312753dex11.htm EX-1.1 TOCAGEN INC. (a Delaware corporation) [●] Shares of Common Stock UNDERWRITING AGREEMENT Leerink Partners LLC Evercore Group L.L.C. as Representatives of the several Underwriters c/o Leerink Partners LLCNew York • May 5th, 2020
EXECUTION VERSION QUINTANA ENERGY SERVICES INC. (a Delaware corporation) 9,259,259 Shares of Common Stock UNDERWRITING AGREEMENT Dated: February 8, 2018 QUINTANA ENERGY SERVICES INC. (a Delaware corporation) 9,259,259 Shares of Common Stock...New York • May 5th, 2020
Quintana Energy Services Inc., a Delaware corporation (the “Company”) confirms its agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Merrill Lynch and Piper Jaffray & Co. (“Piper Jaffray”) are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of Common Stock, par value $0.01 per share, of the Company (“Common Stock”) set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 1,388,889 additional shares of Common Stock. The aforesaid 9,259,25
ContractNew York • May 5th, 2020
EX-1.1 2 exhibit11underwritingagree.htm EXHIBIT 1.1 Exhibit 1.1 EXECUTION VERSION NeoGenomics, Inc. (a Nevada corporation) 7,000,000 Shares of Common Stock UNDERWRITING AGREEMENT May 21, 2019 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 SVB Leerink LLC 1301 Avenue of the Americas, 12th Floor New York, New York 10019 William Blair & Company, L.L.C. 150 North Riverside Plaza Chicago, Illinois 60606 as Representatives of the several Underwriters Ladies and Gentlemen: NeoGenomics, Inc., a Nevada corporation (the “Company”), confirms its agreement with Morgan Stanley & Co. LLC (“Morgan Stanley”), SVB Leerink LLC (“SVB Leerink”) and William Blair & Company, L.L.C. (“William Blair”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for which Morgan Stanley, SVB Leerink and William Blair are acting as representatives (in such
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) 6,250,000 Shares of Common Stock UNDERWRITING AGREEMENTKaryopharm Therapeutics Inc. • March 4th, 2020 • Pharmaceutical preparations • New York
200,000,000 3.250% Fixed to Floating Rate Subordinated Notes due 2030 $175,000,000 3.750% Fixed to Floating Rate Subordinated Notes due 2035 FULTON FINANCIAL CORPORATION UNDERWRITING AGREEMENTFulton Financial Corp • February 26th, 2020 • National commercial banks • New York
Dime Community Bancshares, Inc. 2,608,000 Shares 5.50% Fixed-Rate Non- Cumulative Perpetual Preferred Stock, Series A Underwriting AgreementDime Community Bancshares Inc • January 30th, 2020 • Savings institution, federally chartered • New York
HISTOGENICS CORPORATION (a Delaware corporation) 26,155,000 Shares of Common Stock UNDERWRITING AGREEMENTHistogenics Corp • October 5th, 2018 • Orthopedic, prosthetic & surgical appliances & supplies • New York
UNDERWRITING AGREEMENTNeogenomics Inc • August 10th, 2018 • Services-testing laboratories • New York
VERACYTE, INC. (a Delaware corporation) 5,000,000 Shares of Common Stock UNDERWRITING AGREEMENTVeracyte, Inc. • July 26th, 2018 • Services-medical laboratories • New York
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) 9,152,543 Shares of Common Stock UNDERWRITING AGREEMENTKaryopharm Therapeutics Inc. • May 3rd, 2018 • Pharmaceutical preparations • New York
QUINTANA ENERGY SERVICES INC. (a Delaware corporation) 9,259,259 Shares of Common Stock UNDERWRITING AGREEMENTQuintana Energy Services Inc. • February 14th, 2018 • Oil & gas field services, nec • New York
SYNLOGIC, INC. (a Delaware corporation) 5,130,000 Shares of Common Stock UNDERWRITING AGREEMENTSynlogic, Inc. • January 24th, 2018 • Pharmaceutical preparations • New York
HISTOGENICS CORPORATION (a Delaware corporation) 2,340,430 Shares of Common Stock UNDERWRITING AGREEMENTHistogenics Corp • January 23rd, 2018 • Orthopedic, prosthetic & surgical appliances & supplies • New York
JOHN BEAN TECHNOLOGIES CORPORATION (a Delaware corporation) 2,000,000 Shares of Common Stock UNDERWRITING AGREEMENTJohn Bean Technologies CORP • March 9th, 2017 • Special industry machinery (no metalworking machinery) • New York
TETRA TECHNOLOGIES, INC. (a Delaware corporation) 19,400,000 Shares of Common Stock and Warrants to Purchase 9,700,000 Shares of Common Stock UNDERWRITING AGREEMENTTetra Technologies Inc • December 14th, 2016 • Crude petroleum & natural gas • New York
TRIUMPH BANCORP, INC. (a Texas corporation)Triumph Bancorp, Inc. • September 30th, 2016 • State commercial banks • New York
Triumph Bancorp, Inc., a Texas corporation (the “Company”), confirms its agreement (the “Agreement”) with Sandler O’Neill + Partners, L.P. (“Sandler O’Neill”) and FIG Partners, LLC (“FIG”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Sandler O’Neill and FIG are acting as representatives (in such capacity, the “Representatives”), with respect to the issue and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of $50,000,000 aggregate principal amount of its 6.50% Fixed-to-Floating Rate Subordinated Notes due September 30, 2026 (the “Securities”). The Securities will be issued in book-entry only form to Cede & Co. as nominee of The Depository Trust Company (“DTC”) pursuant to an Indenture between the Company and Wells Fargo Bank, National Association, as Trustee (the “Trustee”), to be
Hannon Armstrong Sustainable Infrastructure Capital, Inc. (a Maryland corporation) 4,000,000 Shares of Common Stock UNDERWRITING AGREEMENTHannon Armstrong Sustainable Infrastructure Capital, Inc. • June 21st, 2016 • Real estate investment trusts • New York
BANC OF CALIFORNIA, INC. (a Maryland corporation) 4,850,000 Shares of Common Stock, $.01 Par Value per Share UNDERWRITING AGREEMENTBanc of California, Inc. • March 8th, 2016 • National commercial banks • New York
Hannon Armstrong Sustainable Infrastructure Capital, Inc. (a Maryland corporation) 5,000,000 Shares of Common Stock UNDERWRITING AGREEMENTHannon Armstrong Sustainable Infrastructure Capital, Inc. • October 19th, 2015 • Real estate investment trusts • New York
Hannon Armstrong Sustainable Infrastructure Capital, Inc. (a Maryland corporation) 4,000,000 Shares of Common Stock UNDERWRITING AGREEMENTHannon Armstrong Sustainable Infrastructure Capital, Inc. • May 4th, 2015 • Real estate investment trusts • New York
